» Articles » PMID: 36832133

Carotid Plaque Vulnerability Diagnosis by CTA Versus MRA: A Systematic Review

Overview
Specialty Radiology
Date 2023 Feb 25
PMID 36832133
Authors
Affiliations
Soon will be listed here.
Abstract

Stenosis grade of the carotid arteries has been the primary indicator for risk stratification and surgical treatment of carotid artery disease. Certain characteristics of the carotid plaque render it vulnerable and have been associated with increased plaque rupture rates. Computed tomography angiography (CTA) and magnetic resonance angiography (MRA) have been shown to detect these characteristics to a different degree. The aim of the current study was to report on the detection of vulnerable carotid plaque characteristics by CTA and MRA and their possible association. A systematic review of the medical literature was executed, utilizing PubMed, SCOPUS and CENTRAL databases, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 guidelines. The study protocol has been registered to PROSPERO (CRD42022381801). Comparative studies reporting on both CTA and MRA carotid artery studies were included in the analysis. The QUADAS tools were used for risk of bias diagnostic imaging studies. Outcomes included carotid plaque vulnerability characteristics described in CTA and MRA and their association. Five studies, incorporating 377 patients and 695 carotid plaques, were included. Four studies reported on symptomatic status (326 patients, 92.9%). MRA characteristics included intraplaque hemorrhage, plaque ulceration, type VI AHA plaque hallmarks and intra-plaque high-intensity signal. Intraplaque hemorrhage detected in MRA was the most described characteristic and was associated with increased plaque density, increased lumen stenosis, plaque ulceration and increased soft-plaque and hard-plaque thickness. Certain characteristics of vulnerable carotid plaques can be detected in carotid artery CTA imaging studies. Nevertheless, MRA continues to provide more detailed and thorough imaging. Both imaging modalities can be applied for comprehensive carotid artery work-up, each one complementing the other.

Citing Articles

Novel imaging modalities for the identification of vulnerable plaques.

Wang Z, Zhang P Front Cardiovasc Med. 2024; 11:1450252.

PMID: 39328242 PMC: 11424440. DOI: 10.3389/fcvm.2024.1450252.


Diagnostic value of artificial intelligence-assisted CTA for the assessment of atherosclerosis plaque: a systematic review and meta-analysis.

Jie P, Fan M, Zhang H, Wang O, Lv J, Liu Y Front Cardiovasc Med. 2024; 11:1398963.

PMID: 39290212 PMC: 11405224. DOI: 10.3389/fcvm.2024.1398963.


Novel Imaging-Based Biomarkers for Identifying Carotid Plaque Vulnerability.

Fernandez-Alvarez V, Linares-Sanchez M, Suarez C, Lopez F, Guntinas-Lichius O, Makitie A Biomolecules. 2023; 13(8).

PMID: 37627301 PMC: 10452902. DOI: 10.3390/biom13081236.

References
1.
STARY H . Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol. 2000; 20(5):1177-8. DOI: 10.1161/01.atv.20.5.1177. View

2.
Kopczak A, Schindler A, Bayer-Karpinska A, Koch M, Sepp D, Zeller J . Complicated Carotid Artery Plaques as a Cause of Cryptogenic Stroke. J Am Coll Cardiol. 2020; 76(19):2212-2222. DOI: 10.1016/j.jacc.2020.09.532. View

3.
Trelles M, Eberhardt K, Buchholz M, Schindler A, Bayer-Karpinska A, Dichgans M . CTA for screening of complicated atherosclerotic carotid plaque--American Heart Association type VI lesions as defined by MRI. AJNR Am J Neuroradiol. 2013; 34(12):2331-7. PMC: 7965199. DOI: 10.3174/ajnr.A3607. View

4.
Eisenmenger L, Aldred B, Kim S, Stoddard G, de Havenon A, Treiman G . Prediction of Carotid Intraplaque Hemorrhage Using Adventitial Calcification and Plaque Thickness on CTA. AJNR Am J Neuroradiol. 2016; 37(8):1496-503. PMC: 7960279. DOI: 10.3174/ajnr.A4765. View

5.
Etesami M, Hoi Y, Steinman D, Gujar S, Nidecker A, Astor B . Comparison of carotid plaque ulcer detection using contrast-enhanced and time-of-flight MRA techniques. AJNR Am J Neuroradiol. 2012; 34(1):177-84. PMC: 7966309. DOI: 10.3174/ajnr.A3132. View